| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/08/2003 | CN1389199A Slow-releasing Tamoxifen citrate tablet |
| 01/08/2003 | CN1098279C Polymerized microemulsion pressure-sensitive adhesive compositions and method of preparing and using same |
| 01/08/2003 | CN1098105C Biodegradable sustained release preparation for treating periodontitis |
| 01/08/2003 | CN1098104C New oral pharmaceutical dosage form |
| 01/08/2003 | CN1098103C Pharmaceutical use of sympathetic human white-cell interferon |
| 01/08/2003 | CN1098090C Drug-dropping capsule and its preparing process |
| 01/08/2003 | CN1098076C Broad-spectrum antifungal oral medicine for treating skin soft tissue infection and syphilitic clap |
| 01/08/2003 | CN1098074C Topical ketoconazole emulsions |
| 01/08/2003 | CN1098071C Transdermal device for delivery of flurbiprofen |
| 01/08/2003 | CN1098069C Transdermal device for delivery of flurbiprofen |
| 01/08/2003 | CN1098068C Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 01/08/2003 | CN1098067C Method and apparatus for preparing liposomes precursor and liposomes with enhanced entrapment capacity, and its use |
| 01/08/2003 | CN1098065C 化学组合物 Chemical composition |
| 01/07/2003 | US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| 01/07/2003 | US6503955 Pourable liquid vehicle comprising polyoxyalkylene block copolymer, glycol and water; used to deliver compositions, materials, and substances to moistened surfaces and aqueous environments |
| 01/07/2003 | US6503927 Amorphous paroxetine composition |
| 01/07/2003 | US6503918 D-mannitol and its preparation |
| 01/07/2003 | US6503911 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 01/07/2003 | US6503896 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 01/07/2003 | US6503894 Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2003 | US6503883 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis |
| 01/07/2003 | US6503878 Binders and polymer coatings with specific glass transition temperature range; improved diametrical fracture stress under low compaction loads; high strength, storage stability |
| 01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
| 01/07/2003 | US6503543 Tryptophan source from plants and uses therefor |
| 01/07/2003 | US6503542 Herbal compositions for treating immunological disorders |
| 01/07/2003 | US6503541 Method for preparation of plant extract powder oral compositions containing plant extract powder prepared by the same |
| 01/07/2003 | US6503537 Preparation of powder agglomerates |
| 01/07/2003 | US6503536 Mixture with solvent and hydrophobic carrier |
| 01/07/2003 | US6503535 Covering with embossing, printing, coloring |
| 01/07/2003 | US6503534 Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/07/2003 | US6503532 Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof |
| 01/07/2003 | US6503531 Of acrylic polymers, tackifiers and antimicrobial agent, diiodomethyl-p-tolylsulfone; heat stability, allows ethylene oxide sterilization; surgical drapes |
| 01/07/2003 | US6503529 Blood type methods and dietary supplements |
| 01/07/2003 | US6503528 Polymeric compositions and a method of making the same |
| 01/07/2003 | US6503524 Surfactant and aqueous zinc salt |
| 01/07/2003 | US6503518 Reduced lipid flowable preparations |
| 01/07/2003 | US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 01/07/2003 | US6503497 Buffers and/or microbiocides |
| 01/07/2003 | US6503494 Composition comprising silicone polymer containing non-silicone backbone and at least one thickening polymer or copolymer of (meth) crylamide or of a (meth) acrylamide derivative |
| 01/07/2003 | US6503482 Non-chlorofluorocarbon aerosol formulations |
| 01/07/2003 | US6503481 Compositions for aerosolization and inhalation |
| 01/07/2003 | US6503480 Aerodynamically light particles for pulmonary drug delivery |
| 01/07/2003 | US6503231 Microneedle device for transport of molecules across tissue |
| 01/07/2003 | CA2229892C Liposome preparations of indolocarbazole derivatives |
| 01/07/2003 | CA2224792C Pharmaceutical preparation containing cyclosporin a |
| 01/07/2003 | CA2220923C Process of high purity albumin production |
| 01/07/2003 | CA2214845C Film-forming pharmaceutical composition for transdermic delivery |
| 01/07/2003 | CA2164844C Methods of preparing gas-filled liposomes |
| 01/06/2003 | WO2003004559A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/06/2003 | CA2445824A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/06/2003 | CA2392288A1 Pharmaceutical preparation for the inhalation of antithrombin in anti-inflammatory lung diseases and ards |
| 01/03/2003 | WO2003000778A1 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 01/03/2003 | WO2003000739A1 Regioselectively reticulated polysaccharides |
| 01/03/2003 | WO2003000692A2 Oxytocin agonists |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000485A1 Method and device for producing compression coated tablets |
| 01/03/2003 | WO2003000343A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 01/03/2003 | WO2003000310A2 Nasal devices |
| 01/03/2003 | WO2003000299A1 Laxative preparation |
| 01/03/2003 | WO2003000295A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | WO2003000294A1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 01/03/2003 | WO2003000293A1 Pharmaceutical formulation |
| 01/03/2003 | WO2003000292A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | WO2003000291A1 Lipid vesicles, process for producing lipid vesicles and method of immobilizing gene on lipid vesicles |
| 01/03/2003 | WO2003000289A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | WO2003000288A1 Methods and compositions for activating endogenous plant pathogen defense pathways |
| 01/03/2003 | WO2003000282A1 Sustained release formulation |
| 01/03/2003 | WO2003000278A1 Ointments |
| 01/03/2003 | WO2003000265A1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 01/03/2003 | WO2003000263A1 Rapid onset formulation |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000248A1 Liquid composition |
| 01/03/2003 | WO2003000243A1 Antimicrobial nanoemulsion compositions and methods |
| 01/03/2003 | WO2003000241A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 01/03/2003 | WO2003000240A2 Stable powder inhalation dosage formulation |
| 01/03/2003 | WO2003000239A1 Stable pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000237A2 Biodegradable polymer coompositions |
| 01/03/2003 | WO2003000236A1 Particles with improved solubilization capacity |
| 01/03/2003 | WO2003000235A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | WO2003000234A1 Porous matrix comprising cross-linked particules |
| 01/03/2003 | WO2003000233A2 Delivery of small hydrophilic molecules packaged into lipid vesicles |
| 01/03/2003 | WO2003000232A2 Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides |
| 01/03/2003 | WO2003000231A1 Hydration compositions for corneal pre-surgery treatment |
| 01/03/2003 | WO2003000230A1 Osmotic implant with membrane and membrane retention means |
| 01/03/2003 | WO2003000229A1 Stable solid delivery system and method of preparing same |
| 01/03/2003 | WO2003000228A2 Method for high through put screening using a small scale mill or microfluidics |
| 01/03/2003 | WO2003000227A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | WO2003000226A2 Pharmaceutical compositions containing polymer and drug assemblies |
| 01/03/2003 | WO2003000225A2 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/03/2003 | WO2003000224A1 Compositions with controlled release of lactic acid at vaginal level |
| 01/03/2003 | WO2003000202A2 Particles for inhalation having rapid release properties |
| 01/03/2003 | WO2003000192A2 Renewable, carbohydrate based co2-philes |
| 01/03/2003 | WO2003000191A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 01/03/2003 | WO2003000190A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 01/03/2003 | WO2003000184A2 Truncated apolipoprotein b-containing lipoprotein particles for delivery of components to tissues or cells |
| 01/03/2003 | WO2003000177A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000174A2 Compositions and methods for intracellular delivery |
| 01/03/2003 | WO2003000169A1 Method of manufacturing tablet |
| 01/03/2003 | WO2003000158A1 Pharmaceutical composition |